{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:09:58Z","timestamp":1785812998225,"version":"3.56.0"},"reference-count":41,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Epileptic seizures are a common and potentially devastating complication of metastatic brain tumors. Although tumor-related seizures have been described in previous case series, most studies have focused on primary brain tumors and have not differentiated between different types of cerebral metastases. The authors analyzed a large surgical cohort of patients with brain metastases to examine risk factors associated with preoperative and postoperative seizures and to better understand the seizure risk factors of metastatic brain tumors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Patients who underwent resection of a brain metastasis at the University of California, San Francisco (UCSF), were retrospectively reviewed. Patients included in the study were \u2265 18 years of age, required resection of a brain metastasis, and were treated at UCSF. Primary cancers included melanoma, non\u2013small cell lung adenocarcinoma, breast adenocarcinoma, colorectal adenocarcinoma, esophageal adenocarcinoma, gastric adenocarcinoma, renal cell carcinoma, urothelial carcinoma, ovarian carcinoma, cervical squamous cell carcinoma, and endometrial adenocarcinoma. Patients were evaluated for primary cancer type and seizure occurrence, as well as need for use of antiepileptic drugs preoperatively, at time of discharge, and at 6 months postoperatively. Additionally, Engel classification scores were assigned to those patients who initially presented with seizures preoperatively. Univariate and multivariate regression analyses were used to assess the association of tumor type with preoperative seizures.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Data were retrospectively analyzed for 348 consecutive patients who underwent surgical treatment of brain metastases between 1998 and 2019. The cohort had a mean age of 60 years at the time of surgery and was 59% female. The mean and median follow-up durations after the date of surgery for the cohort were 22 months and 10.8 months, respectively. In univariate analysis, frontal lobe location (p = 0.05), melanoma (p = 0.02), <jats:italic>KRAS<\/jats:italic> mutation in lung carcinoma (p = 0.04), intratumoral hemorrhage (p = 0.04), and prior radiotherapy (p = 0.04) were associated with seizure presentation. Postoperative checkpoint inhibitor use (p = 0.002), prior radiotherapy (p = 0.05), older age (p = 0.002), distant CNS progression (p = 0.004), and parietal lobe tumor location (p = 0.002) were associated with seizures at 6 months postoperatively. The final multivariate model confirmed the independent effects of tumor location in the frontal lobe and presence of intratumoral hemorrhage as predictors of preoperative seizures, and checkpoint inhibitor use and parietal lobe location were identified as significant predictors of seizures at 6 months postoperatively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Within this surgical cohort of patients with brain metastases, seizures were seen in almost a quarter of patients preoperatively. Frontal lobe metastases and hemorrhagic tumors were associated with higher risk of preoperative seizures, whereas checkpoint inhibitor use and parietal lobe tumors appeared to be associated with seizures at 6 months postoperatively. Future research should focus on the effect of metastatic lesion\u2013targeting therapeutic interventions on seizure control in these patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2022.3.jns212285","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T08:18:44Z","timestamp":1651825124000},"page":"19-26","source":"Crossref","is-referenced-by-count":13,"title":["Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases"],"prefix":"10.3171","volume":"138","author":[{"given":"Joseph H.","family":"Garcia","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin A.","family":"Morshed","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Millares Chavez","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sudhakar","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satvir","family":"Saggi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro N.","family":"Avalos","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"Daras","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"2","key":"b1","series-title":"Curr Treat Options Neurol","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11940-020-0613-y","article-title":"Epilepsy in brain metastasis: an emerging entity","volume":"22","author":"Rud\u00e0 R","year":"2020","unstructured":"Rud\u00e0 R, Mo F, Pellerino A. Epilepsy in brain metastasis: an emerging entity. Curr Treat Options Neurol. 2020;22(2):6.3203453310.1007\/s11940-020-0613-y"},{"issue":"1","key":"b2","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-009-0056-5","article-title":"The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline","volume":"96","author":"Mikkelsen T","year":"2010","unstructured":"Mikkelsen T, Paleologos NA, Robinson PD,  The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):97\u2013102.1995701510.1007\/s11060-009-0056-5"},{"issue":"5","key":"b3","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/neuonc\/noz172","article-title":"Risk factors for the development of epilepsy in patients with brain metastases","volume":"22","author":"Wolpert F","year":"2020","unstructured":"Wolpert F, Lareida A, Terziev R,  Risk factors for the development of epilepsy in patients with brain metastases. Neuro Oncol. 2020;22(5):718\u2013728.3149886710.1093\/neuonc\/noz172"},{"issue":"6","key":"b4","series-title":"Curr Opin Oncol","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/CCO.0b013e32833de99d","article-title":"Epilepsy and brain tumors","volume":"22","author":"Rud\u00e0 R","year":"2010","unstructured":"Rud\u00e0 R, Trevisan E, Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol. 2010;22(6):611\u2013620.2070612110.1097\/CCO.0b013e32833de99d"},{"key":"b5","series-title":"Handb Clin Neurol","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/B978-0-12-802997-8.00016-5","article-title":"Epilepsy and brain tumors","volume":"134","author":"Englot DJ","year":"2016","unstructured":"Englot DJ, Chang EF, Vecht CJ. Epilepsy and brain tumors. Handb Clin Neurol. 2016;134:267\u2013285.2694836010.1016\/B978-0-12-802997-8.00016-5"},{"issue":"21-22","key":"b6","series-title":"Article in German. Wien Klin Wochenschr","first-page":"911","article-title":"The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna","volume":"114","author":"Oberndorfer S","year":"2002","unstructured":"Oberndorfer S, Schmal T, Lahrmann H, Urbanits S, Lindner K, Grisold W. The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Article in German. Wien Klin Wochenschr. 2002;114(21-22):911\u2013916.12528323"},{"issue":"8","key":"b7","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi HA","year":"2018","unstructured":"Tawbi HA, Forsyth PA, Algazi A,  Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379(8):722\u2013730.10.1056\/NEJMoa1805453"},{"issue":"7","key":"b8","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg SB","year":"2016","unstructured":"Goldberg SB, Gettinger SN, Mahajan A,  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17(7):976\u2013983.2726760810.1016\/S1470-2045(16)30053-5"},{"issue":"5","key":"b9","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(12)70090-6","article-title":"Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial","volume":"13","author":"Margolin K","year":"2012","unstructured":"Margolin K, Ernstoff MS, Hamid O,  Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol. 2012;13(5):459\u2013465.2245642910.1016\/S1470-2045(12)70090-6"},{"issue":"5","key":"b10","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long GV","year":"2018","unstructured":"Long GV, Atkinson V, Lo S,  Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol. 2018;19(5):672\u2013681.2960264610.1016\/S1470-2045(18)30139-6"},{"issue":"1","key":"b11","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-012-0802-y","article-title":"Seizure prophylaxis and melanoma brain metastases","volume":"108","author":"Goldlust SA","year":"2012","unstructured":"Goldlust SA, Hsu M, Lassman AB, Panageas KS, Avila EK. Seizure prophylaxis and melanoma brain metastases. J Neurooncol. 2012;108(1):109\u2013114.2231110610.1007\/s11060-012-0802-y"},{"issue":"15","key":"b12","series-title":"PharmacoEconomics","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/00019053-200220150-00002","article-title":"Quality of life in patients with epilepsy and impact of treatments","volume":"20","author":"Berto P","year":"2002","unstructured":"Berto P. Quality of life in patients with epilepsy and impact of treatments. PharmacoEconomics. 2002;20(15):1039\u20131059.1245620010.2165\/00019053-200220150-00002"},{"issue":"2","key":"b13","series-title":"J Clin Neurophysiol","first-page":"143","article-title":"Seizures in patients with metastatic brain tumors: prevalence, clinical characteristics, and features on EEG","volume":"38","author":"Ajinkya S","year":"2021","unstructured":"Ajinkya S, Fox J, Houston P,  Seizures in patients with metastatic brain tumors: prevalence, clinical characteristics, and features on EEG. J Clin Neurophysiol. 2021;38(2):143\u2013148.31856045"},{"issue":"7","key":"b14","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.clineuro.2007.05.017","article-title":"Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review","volume":"109","author":"Lynam LM","year":"2007","unstructured":"Lynam LM, Lyons MK, Drazkowski JF,  Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007;109(7):634\u2013638.1760165810.1016\/j.clineuro.2007.05.017"},{"issue":"1","key":"b15","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-009-0069-0","article-title":"Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy","volume":"98","author":"Maschio M","year":"2010","unstructured":"Maschio M, Dinapoli L, Gomellini S,  Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J Neurooncol. 2010;98(1):109\u2013116.1993708710.1007\/s11060-009-0069-0"},{"issue":"8","key":"b16","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1212\/WNL.0000000000011459","article-title":"Seizures among patients with brain metastases: a population- and institutional-level analysis","volume":"96","author":"Lamba N","year":"2021","unstructured":"Lamba N, Catalano PJ, Cagney DN,  Seizures among patients with brain metastases: a population- and institutional-level analysis. Neurology. 2021;96(8):e1237\u2013e1250.3340244110.1212\/WNL.0000000000011459"},{"issue":"Pt 4","key":"b17","series-title":"Brain","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/brain\/awr310","article-title":"Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment","volume":"135","author":"de Groot M","year":"2012","unstructured":"de Groot M, Reijneveld JC, Aronica E, Heimans JJ. Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain. 2012;135(Pt 4):1002\u20131016.2217135110.1093\/brain\/awr310"},{"issue":"9","key":"b18","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.0b013e3182494d40","article-title":"Epileptic seizures at initial presentation in patients with brain arteriovenous malformation","volume":"78","author":"Garcin B","year":"2012","unstructured":"Garcin B, Houdart E, Porcher R,  Epileptic seizures at initial presentation in patients with brain arteriovenous malformation. Neurology. 2012;78(9):626\u2013631.2234521710.1212\/WNL.0b013e3182494d40"},{"issue":"7","key":"b19","series-title":"Epilepsia","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1528-1157.2002.39501.x","article-title":"Frontal lobe tumoral epilepsy: clinical, neurophysiologic features and predictors of surgical outcome","volume":"43","author":"Zaatreh MM","year":"2002","unstructured":"Zaatreh MM, Spencer DD, Thompson JL,  Frontal lobe tumoral epilepsy: clinical, neurophysiologic features and predictors of surgical outcome. Epilepsia. 2002;43(7):727\u2013733.1210267510.1046\/j.1528-1157.2002.39501.x"},{"issue":"6","key":"b20","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3171\/2021.6.PEDS21126","article-title":"Factors associated with seizures at initial presentation in pediatric patients with cerebral arteriovenous malformations","volume":"28","author":"Garcia JH","year":"2021","unstructured":"Garcia JH, Winkler EA, Morshed RA,  Factors associated with seizures at initial presentation in pediatric patients with cerebral arteriovenous malformations. J Neurosurg Pediatr. 2021;28(6):663\u2013668.10.3171\/2021.6.PEDS21126"},{"key":"b21","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.nbd.2019.03.015","article-title":"Multiscale recordings reveal the dynamic spatial structure of human seizures","volume":"127","author":"Schevon CA","year":"2019","unstructured":"Schevon CA, Tobochnik S, Eissa T,  Multiscale recordings reveal the dynamic spatial structure of human seizures. Neurobiol Dis. 2019;127:303\u2013311.3089866910.1016\/j.nbd.2019.03.015"},{"issue":"Pt 2","key":"b22","series-title":"Brain","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"van Vliet EA","year":"2007","unstructured":"van Vliet EA, da Costa Ara\u00fajo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007;130(Pt 2):521\u2013534.10.1093\/brain\/awl318"},{"key":"b23","article-title":"The Treatment of Epilepsy","author":"Shorvon SD","year":"2004","unstructured":"Shorvon SD, Perucca E, Fish DR, Dodson WE. The Treatment of Epilepsy. 2nd ed. Blackwell Publishing;2004."},{"issue":"Pt 2","key":"b24","series-title":"Brain","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/brain\/awl317","article-title":"TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis","volume":"130","author":"Ivens S","year":"2007","unstructured":"Ivens S, Kaufer D, Flores LP,  TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 2007;130(Pt 2):535\u2013547.1712174410.1093\/brain\/awl317"},{"issue":"10","key":"b25","series-title":"Mol Cells","first-page":"881","article-title":"Brain somatic mutations in epileptic disorders","volume":"41","author":"Koh HY","year":"2018","unstructured":"Koh HY, Lee JH. Brain somatic mutations in epileptic disorders. Mol Cells. 2018;41(10):881\u2013888.30352490"},{"key":"b26","series-title":"ScientificWorldJournal","doi-asserted-by":"publisher","first-page":"403942","DOI":"10.1155\/2013\/403942","article-title":"The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas","volume":"2013","author":"Liang R","year":"2013","unstructured":"Liang R, Fan Y, Wang X, Mao Q, Liu Y. The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas. ScientificWorldJournal. 2013;2013:403942.2432437210.1155\/2013\/403942"},{"issue":"1","key":"b27","series-title":"Oncoimmunology","doi-asserted-by":"publisher","first-page":"1851517","DOI":"10.1080\/2162402X.2020.1851517","article-title":"Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition","volume":"9","author":"Urban H","year":"2020","unstructured":"Urban H, Willems LM, Ronellenfitsch MW, Rosenow F, Steinbach JP, Strzelczyk A. Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition. Oncoimmunology. 2020;9(1):1851517.3329966210.1080\/2162402X.2020.1851517"},{"issue":"2","key":"b28","series-title":"Case Rep Oncol","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000477162","article-title":"PD-1 checkpoint inhibitor associated autoimmune encephalitis","volume":"10","author":"Schneider S","year":"2017","unstructured":"Schneider S, Potthast S, Komminoth P, Schwegler G, B\u00f6hm S. PD-1 checkpoint inhibitor associated autoimmune encephalitis. Case Rep Oncol. 2017;10(2):473\u2013478.2862640810.1159\/000477162"},{"issue":"Suppl 7","key":"b29","series-title":"Rheumatology (Oxford)","doi-asserted-by":"publisher","first-page":"vii7","DOI":"10.1093\/rheumatology\/kez418","article-title":"Toxicities associated with checkpoint inhibitors-an overview","volume":"58","author":"Spiers L","year":"2019","unstructured":"Spiers L, Coupe N, Payne M. Toxicities associated with checkpoint inhibitors-an overview. Rheumatology (Oxford). 2019;58(Suppl 7):vii7\u2013vii16.3181608510.1093\/rheumatology\/kez418"},{"issue":"6","key":"b30","series-title":"Curr Opin Neurol","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/WCO.0000000000000503","article-title":"Neurological toxicities associated with immune-checkpoint inhibitors","volume":"30","author":"Touat M","year":"2017","unstructured":"Touat M, Talmasov D, Ricard D, Psimaras D. Neurological toxicities associated with immune-checkpoint inhibitors. Curr Opin Neurol. 2017;30(6):659\u2013668.2893834110.1097\/WCO.0000000000000503"},{"issue":"6","key":"b31","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3171\/2008.2.17665","article-title":"Surgical treatment of parietal lobe epilepsy","volume":"110","author":"Binder DK","year":"2009","unstructured":"Binder DK, Podlogar M, Clusmann H,  Surgical treatment of parietal lobe epilepsy. J Neurosurg. 2009;110(6):1170\u20131178.1919950210.3171\/2008.2.17665"},{"issue":"3","key":"b32","series-title":"Noro Psikiyatri Arsivi","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5152\/npa.2016.13790","article-title":"Refractory lesional parietal lobe epilepsy: clinical, electroencephalographic and neurodiagnostic findings","volume":"53","author":"Kur\u015fun O","year":"2016","unstructured":"Kur\u015fun O, Karata\u015f H, Dericio\u011flu N, Saygi S. Refractory lesional parietal lobe epilepsy: clinical, electroencephalographic and neurodiagnostic findings. Noro Psikiyatri Arsivi. 2016;53(3):213\u2013221.2837379710.5152\/npa.2016.13790"},{"issue":"3","key":"b33","series-title":"Arch Neurol","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/archneurol.2010.2","article-title":"Morphological characteristics of brain tumors causing seizures","volume":"67","author":"Lee JW","year":"2010","unstructured":"Lee JW, Wen PY, Hurwitz S,  Morphological characteristics of brain tumors causing seizures. Arch Neurol. 2010;67(3):336\u2013342.2021223110.1001\/archneurol.2010.2"},{"issue":"1","key":"b34","series-title":"Epileptic Disord","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1684\/epd.2012.0484","article-title":"Parietal lobe epilepsy: the great imitator among focal epilepsies","volume":"14","author":"Risti\u0107 AJ","year":"2012","unstructured":"Risti\u0107 AJ, Alexopoulos AV, So N, Wong C, Najm IM. Parietal lobe epilepsy: the great imitator among focal epilepsies. Epileptic Disord. 2012;14(1):22\u201331.2242641210.1684\/epd.2012.0484"},{"issue":"7","key":"b35","series-title":"Oncologist","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","article-title":"Seizure prognosis in brain tumors: new insights and evidence-based management","volume":"19","author":"Vecht CJ","year":"2014","unstructured":"Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014;19(7):751\u2013759.2489964510.1634\/theoncologist.2014-0060"},{"issue":"1","key":"b36","series-title":"Prog Neuropsychopharmacol Biol Psychiatry","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pnpbp.2010.11.026","article-title":"Gerstmann\u2019s syndrome and HAART adherence: a case report in a patient co-infected with HIV-1\/HCV","volume":"35","author":"Margalho R","year":"2011","unstructured":"Margalho R, Mendon\u00e7a N, Gidron Y, Pereira M. Gerstmann\u2019s syndrome and HAART adherence: a case report in a patient co-infected with HIV-1\/HCV. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(1):308\u2013309.10.1016\/j.pnpbp.2010.11.026"},{"issue":"5","key":"b37","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.ijrobp.2009.01.010","article-title":"Adult supratentorial low-grade glioma: long-term experience at a single institution","volume":"75","author":"Bauman G","year":"2009","unstructured":"Bauman G, Fisher B, Watling C, Cairncross JG, Macdonald D. Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radiat Oncol Biol Phys. 2009;75(5):1401\u20131407.10.1016\/j.ijrobp.2009.01.010"},{"issue":"5","key":"b38","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/neuonc\/nov238","article-title":"Prognostic relevance of epilepsy at presentation in glioblastoma patients","volume":"18","author":"Berendsen S","year":"2016","unstructured":"Berendsen S, Varkila M, Kroonen J,  Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro Oncol. 2016;18(5):700\u2013706.2642089610.1093\/neuonc\/nov238"},{"key":"b39","series-title":"Seizure","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.seizure.2018.04.018","article-title":"Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma: a systematic review and meta-analysis","volume":"59","author":"Fan X","year":"2018","unstructured":"Fan X, Li Y, Shan X,  Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma: a systematic review and meta-analysis. Seizure. 2018;59:16\u201323.2972774110.1016\/j.seizure.2018.04.018"},{"issue":"5","key":"b40","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1474-4422(05)70072-7","article-title":"Therapeutic management of brain metastasis","volume":"4","author":"Kaal EC","year":"2005","unstructured":"Kaal EC, Ni\u00ebl CG, Vecht CJ. Therapeutic management of brain metastasis. Lancet Neurol. 2005;4(5):289\u2013298.1584784210.1016\/S1474-4422(05)70072-7"},{"issue":"8","key":"b41","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell RA","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW,  A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494\u2013500.10.1056\/NEJM199002223220802"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/138\/1\/article-p19.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/138\/1\/article-p19.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/138\/1\/article-p19.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:14:39Z","timestamp":1732194879000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/138\/1\/article-p19.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":41,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2022.3.jns212285","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}